SEC Form 4 · accession 0001209191-16-153891
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ALAFI CAPITAL CO LLC
10% Owner
Period of report
Dec 6, 2016
Accepted (ET)
Dec 7, 2016 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 6, 2016 | P | 44,174 | $16.3319 | A | 3,674,379 | D | |
| Common StockF2 | Dec 7, 2016 | P | 20,826 | $16.1355 | A | 3,695,205 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.28 to $16.50 per share, inclusive.
- F2The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.91 to $16.37 per share, inclusive.